Neervannan Seshadri, Chief Operating Officer of Tarsus Pharmaceuticals ($TARS), sold company shares on the open market four times in the last year, totaling $1.0 million. His most recent sale occurred on March 4, 2026. These sales rank him 4,906th among 11,678 insiders for highest total sold, below the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 2989 | $66.75 | 83,266.0000 | 42,607,717 | 3.47% | 0.01% |
| March 17, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 3125 | $69.42 | 94,454.0000 | 42,607,717 | 3.20% | 0.01% |
| March 19, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 4589 | $67.00 | 86,255.0000 | 42,607,717 | 5.05% | 0.01% |
| March 18, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 3610 | $68.71 | 90,844.0000 | 42,607,717 | 3.82% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Restricted Stock Units | 5022 | $0.00 | 15,067.0000 | 42,607,717 | 25.00% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Common Stock | 26287 | $0.00 | 97,579.0000 | 42,607,717 | 36.87% | 0.06% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Restricted Stock Units | 5097 | $0.00 | 0.0000 | 42,607,717 | 100.00% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Restricted Stock Units | 8148 | $0.00 | 8,148.0000 | 42,607,717 | 50.00% | 0.02% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Restricted Stock Units | 8020 | $0.00 | 16,040.0000 | 42,607,717 | 33.33% | 0.02% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | A | Restricted Stock Units | 17161 | $0.00 | 17,161.0000 | 42,607,717 | 9999.99% | 0.04% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | A | Stock Option (right to buy) | 27310 | $0.00 | 27,310.0000 | 42,607,717 | 9999.99% | 0.06% |
| March 4, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 8366 | $76.67 | 71,292.0000 | 42,607,717 | 10.50% | 0.02% |
| Dec. 16, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | G | Common Stock | 475 | $0.00 | 79,658.0000 | 42,607,717 | 0.60% | 0.00% |
| Dec. 16, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | G | Common Stock | 950 | $0.00 | 79,658.0000 | 42,607,717 | 1.18% | 0.00% |
| March 20, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 2435 | $50.11 | 79,682.0000 | 37,604,538 | 2.97% | 0.01% |
| March 18, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 2605 | $46.29 | 84,660.0000 | 37,604,538 | 2.99% | 0.01% |
| March 19, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 2543 | $47.40 | 82,117.0000 | 37,604,538 | 3.00% | 0.01% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Restricted Stock Units | 8019 | $0.00 | 24,060.0000 | 37,604,538 | 25.00% | 0.02% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Restricted Stock Units | 5097 | $0.00 | 5,097.0000 | 37,604,538 | 50.00% | 0.01% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Common Stock | 21264 | $0.00 | 87,265.0000 | 37,604,538 | 32.22% | 0.06% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Restricted Stock Units | 8148 | $0.00 | 16,296.0000 | 37,604,538 | 33.33% | 0.02% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | A | Stock Option (right to buy) | 30628 | $0.00 | 30,628.0000 | 37,604,538 | 9999.99% | 0.08% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | A | Restricted Stock Units | 20089 | $0.00 | 20,089.0000 | 37,604,538 | 9999.99% | 0.05% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Common Stock | 13245 | $0.00 | 69,646.0000 | 29,383,276 | 23.48% | 0.05% |
| March 18, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 4879 | $30.60 | 64,767.0000 | 29,383,276 | 7.01% | 0.02% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Restricted Stock Units | 5097 | $0.00 | 10,194.0000 | 29,383,276 | 33.33% | 0.02% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Restricted Stock Units | 8148 | $0.00 | 24,444.0000 | 29,383,276 | 25.00% | 0.03% |
| March 7, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | A | Restricted Stock Units | 32079 | $0.00 | 32,079.0000 | 29,383,276 | 9999.99% | 0.11% |
| March 7, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | A | Stock Option (right to buy) | 47500 | $0.00 | 47,500.0000 | 29,383,276 | 9999.99% | 0.16% |
| March 21, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 372 | $12.89 | 55,465.0000 | 24,619,700 | 0.67% | 0.00% |
| March 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 379 | $12.64 | 55,086.0000 | 24,619,700 | 0.68% | 0.00% |
| March 23, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 390 | $12.15 | 54,696.0000 | 24,619,700 | 0.71% | 0.00% |
| March 20, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 380 | $12.61 | 55,837.0000 | 24,619,700 | 0.68% | 0.00% |
| March 17, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 360 | $13.28 | 56,217.0000 | 24,619,700 | 0.64% | 0.00% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Common Stock | 5097 | $0.00 | 56,934.0000 | 24,619,700 | 9.83% | 0.02% |
| March 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | S | Common Stock | 357 | $13.43 | 56,577.0000 | 24,619,700 | 0.63% | 0.00% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | M | Restricted Stock Units | 5097 | $0.00 | 15,291.0000 | 24,619,700 | 25.00% | 0.02% |
| March 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | A | Restricted Stock Units | 32592 | $0.00 | 32,592.0000 | 24,619,700 | 9999.99% | 0.13% |
| March 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Neervannan Seshadri | Chief Operating Officer | A | Stock Option (right to buy) | 48116 | $0.00 | 48,116.0000 | 24,619,700 | 9999.99% | 0.20% |